↑ Rising Health 🔮 fades FDA raised conflict of interest concerns ahead of new peptide panel Regulatory scrutiny intensifies as the FDA prepares for a critical panel review on the safety and oversight of peptide substances. 6 sources 6 articles v 11 14h ago
◼ Archived Business 🔮 fades ✓ FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr. An upcoming FDA advisory panel review of seven peptide compounds has triggered scrutiny regarding potential conflicts of interest among selected experts. 6 sources 6 articles v 4 17d ago